APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advanced Perfusion System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Advanced Perfusion System Market Outlook and Growth Opportunities 2026

4 July 2026190 pages

Choose your research edition.

Industry ResearchAdvanced Perfusion System Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Advanced Perfusion System Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Advanced Perfusion System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advanced Perfusion System Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Advanced Perfusion System Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Advanced Perfusion System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Advanced Perfusion System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Advanced Perfusion System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Advanced Perfusion System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Advanced Perfusion System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Advanced Perfusion System market include Sorin, MAQUET, Medtronic, Terumo, Braile Biomedica, Tianjin Medical and Getinge, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Advanced Perfusion System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Advanced Perfusion System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Advanced Perfusion System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Advanced Perfusion System market size, projected growth trends, production technologies, key applications, and end-use industries.

Advanced Perfusion System Segment by Company

Sorin

MAQUET

Medtronic

Terumo

Braile Biomedica

Tianjin Medical

Getinge

Advanced Perfusion System Segment by Type

Single Roller Pump Heart Lung Machine

Double Roller Pump Heart Lung Machine

Advanced Perfusion System Segment by Application

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Advanced Perfusion System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Advanced Perfusion System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Advanced Perfusion System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Advanced Perfusion System significant trends, drivers, influence factors in global and regions.

6. To analyze Advanced Perfusion System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Perfusion System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advanced Perfusion System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Perfusion System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Advanced Perfusion System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Advanced Perfusion System industry.

Chapter 3: Detailed analysis of Advanced Perfusion System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Advanced Perfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Advanced Perfusion System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Advanced Perfusion System Industry Trends Table 2. Advanced Perfusion System Industry Drivers Table 3. Advanced Perfusion System Industry Opportunities and Challenges Table 4. Advanced Perfusion System Industry Restraints Table 5. Global Advanced Perfusion System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Advanced Perfusion System Revenue Share by Company (2021-2026) Table 7. Global Advanced Perfusion System Sales Volume by Company (k units) & (2021-2026) Table 8. Global Advanced Perfusion System Sales Volume Share by Company (2021-2026) Table 9. Global Advanced Perfusion System Average Price (USD/unit) of Company (2021-2026) Table 10. Global Advanced Perfusion System Company Ranking, (2024-2026) & (USD Million) Table 11. Global Advanced Perfusion System Key Company Manufacturing Base & Headquarters Table 12. Global Advanced Perfusion System Company, Product Type & Application Table 13. Global Advanced Perfusion System Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Advanced Perfusion System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Roller Pump Heart Lung Machine Table 18. Significant Companies of Double Roller Pump Heart Lung Machine Table 19. Global Advanced Perfusion System Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Advanced Perfusion System Sales Volume by Type (2021-2026) & (k units) Table 21. Global Advanced Perfusion System Sales Volume by Type (2027-2032) & (k units) Table 22. Global Advanced Perfusion System Sales Volume Share by Type (2021-2026) Table 23. Global Advanced Perfusion System Sales Volume Share by Type (2027-2032) Table 24. Global Advanced Perfusion System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Advanced Perfusion System Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Advanced Perfusion System Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Advanced Perfusion System Sales Value Share by Type (2021-2026) Table 28. Global Advanced Perfusion System Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cardiac Surgery Table 30. Significant Companies of Lung Transplant Operation Table 31. Significant Companies of Acute Respiratory Failure Treatment Table 32. Significant Companies of Others Table 33. Global Advanced Perfusion System Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Advanced Perfusion System Sales Volume by Application (2021-2026) & (k units) Table 35. Global Advanced Perfusion System Sales Volume by Application (2027-2032) & (k units) Table 36. Global Advanced Perfusion System Sales Volume Share by Application (2021-2026) Table 37. Global Advanced Perfusion System Sales Volume Share by Application (2027-2032) Table 38. Global Advanced Perfusion System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Advanced Perfusion System Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Advanced Perfusion System Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Advanced Perfusion System Sales Value Share by Application (2021-2026) Table 42. Global Advanced Perfusion System Sales Value Share by Application (2027-2032) Table 43. Global Advanced Perfusion System Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Advanced Perfusion System Sales by Region (2021-2026) & (k units) Table 45. Global Advanced Perfusion System Sales Market Share by Region (2021-2026) Table 46. Global Advanced Perfusion System Sales by Region (2027-2032) & (k units) Table 47. Global Advanced Perfusion System Sales Market Share by Region (2027-2032) Table 48. Global Advanced Perfusion System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Advanced Perfusion System Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Advanced Perfusion System Sales Value Share by Region (2021-2026) Table 51. Global Advanced Perfusion System Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Advanced Perfusion System Sales Value Share by Region (2027-2032) Table 53. Global Advanced Perfusion System Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Advanced Perfusion System Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Advanced Perfusion System Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Advanced Perfusion System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Advanced Perfusion System Sales by Country (2021-2026) & (k units) Table 58. Global Advanced Perfusion System Sales Market Share by Country (2021-2026) Table 59. Global Advanced Perfusion System Sales by Country (2027-2032) & (k units) Table 60. Global Advanced Perfusion System Sales Market Share by Country (2027-2032) Table 61. Global Advanced Perfusion System Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Advanced Perfusion System Sales Value Market Share by Country (2021-2026) Table 63. Global Advanced Perfusion System Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Advanced Perfusion System Sales Value Market Share by Country (2027-2032) Table 65. Sorin Company Information Table 66. Sorin Business Overview Table 67. Sorin Advanced Perfusion System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Sorin Advanced Perfusion System Product Portfolio Table 69. Sorin Recent Development Table 70. MAQUET Company Information Table 71. MAQUET Business Overview Table 72. MAQUET Advanced Perfusion System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. MAQUET Advanced Perfusion System Product Portfolio Table 74. MAQUET Recent Development Table 75. Medtronic Company Information Table 76. Medtronic Business Overview Table 77. Medtronic Advanced Perfusion System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Medtronic Advanced Perfusion System Product Portfolio Table 79. Medtronic Recent Development Table 80. Terumo Company Information Table 81. Terumo Business Overview Table 82. Terumo Advanced Perfusion System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Terumo Advanced Perfusion System Product Portfolio Table 84. Terumo Recent Development Table 85. Braile Biomedica Company Information Table 86. Braile Biomedica Business Overview Table 87. Braile Biomedica Advanced Perfusion System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Braile Biomedica Advanced Perfusion System Product Portfolio Table 89. Braile Biomedica Recent Development Table 90. Tianjin Medical Company Information Table 91. Tianjin Medical Business Overview Table 92. Tianjin Medical Advanced Perfusion System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Tianjin Medical Advanced Perfusion System Product Portfolio Table 94. Tianjin Medical Recent Development Table 95. Getinge Company Information Table 96. Getinge Business Overview Table 97. Getinge Advanced Perfusion System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Getinge Advanced Perfusion System Product Portfolio Table 99. Getinge Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Advanced Perfusion System Distributors List Table 103. Advanced Perfusion System Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Advanced Perfusion System Product Image Figure 2. Global Advanced Perfusion System Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advanced Perfusion System Sales Value (2021-2032) & (US$ Million) Figure 4. Global Advanced Perfusion System Sales (2021-2032) & (k units) Figure 5. Global Advanced Perfusion System Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Advanced Perfusion System Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Roller Pump Heart Lung Machine Image Figure 10. Double Roller Pump Heart Lung Machine Image Figure 11. Global Advanced Perfusion System Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Advanced Perfusion System Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Advanced Perfusion System Sales Volume Share by Type (2021-2032) Figure 14. Global Advanced Perfusion System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Advanced Perfusion System Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Advanced Perfusion System Sales Value Share by Type (2021-2032) Figure 17. Cardiac Surgery Image Figure 18. Lung Transplant Operation Image Figure 19. Acute Respiratory Failure Treatment Image Figure 20. Others Image Figure 21. Global Advanced Perfusion System Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Advanced Perfusion System Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Advanced Perfusion System Sales Volume Share by Application (2021-2032) Figure 24. Global Advanced Perfusion System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Advanced Perfusion System Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Advanced Perfusion System Sales Value Share by Application (2021-2032) Figure 27. Global Advanced Perfusion System Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Advanced Perfusion System Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Advanced Perfusion System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Advanced Perfusion System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Advanced Perfusion System Sales Value (2021-2032) & (US$ Million) Figure 32. North America Advanced Perfusion System Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Advanced Perfusion System Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Advanced Perfusion System Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Advanced Perfusion System Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Advanced Perfusion System Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Advanced Perfusion System Sales Value (2021-2032) & (US$ Million) Figure 38. South America Advanced Perfusion System Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Advanced Perfusion System Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Advanced Perfusion System Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Advanced Perfusion System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Advanced Perfusion System Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Advanced Perfusion System Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Single Roller Pump Heart Lung Machine
  • Double Roller Pump Heart Lung Machine
Applications
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Companies covered
  • Sorin
  • MAQUET
  • Medtronic
  • Terumo
  • Braile Biomedica
  • Tianjin Medical
  • Getinge

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Advanced Perfusion System Sales Value (2021-2032)
  4. 1.2.2 Global Advanced Perfusion System Sales Volume (2021-2032)
  5. 1.2.3 Global Advanced Perfusion System Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Advanced Perfusion System Market Dynamics
  1. 2.1 Advanced Perfusion System Industry Trends
  2. 2.2 Advanced Perfusion System Industry Drivers
  3. 2.3 Advanced Perfusion System Industry Opportunities and Challenges
  4. 2.4 Advanced Perfusion System Industry Restraints
3 Advanced Perfusion System Market by Company
  1. 3.1 Global Advanced Perfusion System Company Revenue Ranking in 2025
  2. 3.2 Global Advanced Perfusion System Revenue by Company (2021-2026)
  3. 3.3 Global Advanced Perfusion System Sales Volume by Company (2021-2026)
  4. 3.4 Global Advanced Perfusion System Average Price by Company (2021-2026)
  5. 3.5 Global Advanced Perfusion System Company Ranking (2024-2026)
  6. 3.6 Global Advanced Perfusion System Company Manufacturing Base and Headquarters
  7. 3.7 Global Advanced Perfusion System Company Product Type and Application
  8. 3.8 Global Advanced Perfusion System Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Advanced Perfusion System Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Advanced Perfusion System Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Advanced Perfusion System Market by Type
  1. 4.1 Advanced Perfusion System Type Introduction
  2. 4.1.1 Single Roller Pump Heart Lung Machine
  3. 4.1.2 Double Roller Pump Heart Lung Machine
  4. 4.2 Global Advanced Perfusion System Sales Volume by Type
  5. 4.2.1 Global Advanced Perfusion System Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Advanced Perfusion System Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Advanced Perfusion System Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Advanced Perfusion System Sales Value by Type
  9. 4.3.1 Global Advanced Perfusion System Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Advanced Perfusion System Sales Value by Type (2021-2032)
  11. 4.3.3 Global Advanced Perfusion System Sales Value Share by Type (2021-2032)
5 Advanced Perfusion System Market by Application
  1. 5.1 Advanced Perfusion System Application Introduction
  2. 5.1.1 Cardiac Surgery
  3. 5.1.2 Lung Transplant Operation
  4. 5.1.3 Acute Respiratory Failure Treatment
  5. 5.1.4 Others
  6. 5.2 Global Advanced Perfusion System Sales Volume by Application
  7. 5.2.1 Global Advanced Perfusion System Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Advanced Perfusion System Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Advanced Perfusion System Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Advanced Perfusion System Sales Value by Application
  11. 5.3.1 Global Advanced Perfusion System Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Advanced Perfusion System Sales Value by Application (2021-2032)
  13. 5.3.3 Global Advanced Perfusion System Sales Value Share by Application (2021-2032)
6 Advanced Perfusion System Regional Sales and Value Analysis
  1. 6.1 Global Advanced Perfusion System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Advanced Perfusion System Sales by Region (2021-2032)
  3. 6.2.1 Global Advanced Perfusion System Sales by Region: 2021-2026
  4. 6.2.2 Global Advanced Perfusion System Sales by Region (2027-2032)
  5. 6.3 Global Advanced Perfusion System Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Advanced Perfusion System Sales Value by Region (2021-2032)
  7. 6.4.1 Global Advanced Perfusion System Sales Value by Region: 2021-2026
  8. 6.4.2 Global Advanced Perfusion System Sales Value by Region (2027-2032)
  9. 6.5 Global Advanced Perfusion System Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Advanced Perfusion System Sales Value (2021-2032)
  12. 6.6.2 North America Advanced Perfusion System Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Advanced Perfusion System Sales Value (2021-2032)
  15. 6.7.2 Europe Advanced Perfusion System Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Advanced Perfusion System Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Advanced Perfusion System Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Advanced Perfusion System Sales Value (2021-2032)
  21. 6.9.2 South America Advanced Perfusion System Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Advanced Perfusion System Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Advanced Perfusion System Sales Value Share by Country, 2025 VS 2032
7 Advanced Perfusion System Country-level Sales and Value Analysis
  1. 7.1 Global Advanced Perfusion System Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Advanced Perfusion System Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Advanced Perfusion System Sales by Country (2021-2032)
  4. 7.3.1 Global Advanced Perfusion System Sales by Country (2021-2026)
  5. 7.3.2 Global Advanced Perfusion System Sales by Country (2027-2032)
  6. 7.4 Global Advanced Perfusion System Sales Value by Country (2021-2032)
  7. 7.4.1 Global Advanced Perfusion System Sales Value by Country (2021-2026)
  8. 7.4.2 Global Advanced Perfusion System Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Advanced Perfusion System Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Advanced Perfusion System Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Advanced Perfusion System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sorin
  2. 8.1.1 Sorin Company Information
  3. 8.1.2 Sorin Business Overview
  4. 8.1.3 Sorin Advanced Perfusion System Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sorin Advanced Perfusion System Product Portfolio
  6. 8.1.5 Sorin Recent Developments
  7. 8.2 MAQUET
  8. 8.2.1 MAQUET Company Information
  9. 8.2.2 MAQUET Business Overview
  10. 8.2.3 MAQUET Advanced Perfusion System Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MAQUET Advanced Perfusion System Product Portfolio
  12. 8.2.5 MAQUET Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Advanced Perfusion System Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Advanced Perfusion System Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Advanced Perfusion System Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Advanced Perfusion System Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Braile Biomedica
  26. 8.5.1 Braile Biomedica Company Information
  27. 8.5.2 Braile Biomedica Business Overview
  28. 8.5.3 Braile Biomedica Advanced Perfusion System Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Braile Biomedica Advanced Perfusion System Product Portfolio
  30. 8.5.5 Braile Biomedica Recent Developments
  31. 8.6 Tianjin Medical
  32. 8.6.1 Tianjin Medical Company Information
  33. 8.6.2 Tianjin Medical Business Overview
  34. 8.6.3 Tianjin Medical Advanced Perfusion System Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Medical Advanced Perfusion System Product Portfolio
  36. 8.6.5 Tianjin Medical Recent Developments
  37. 8.7 Getinge
  38. 8.7.1 Getinge Company Information
  39. 8.7.2 Getinge Business Overview
  40. 8.7.3 Getinge Advanced Perfusion System Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Getinge Advanced Perfusion System Product Portfolio
  42. 8.7.5 Getinge Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Advanced Perfusion System Value Chain Analysis
  2. 9.1.1 Advanced Perfusion System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Advanced Perfusion System Sales Mode & Process
  6. 9.2 Advanced Perfusion System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Advanced Perfusion System Distributors
  9. 9.2.3 Advanced Perfusion System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst